Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#690 Primary Lymph Node Gastrinoma or Metastatic Gastrinoma with Unidentified Primary Tumor Site?
Introduction: The existence of primary lymph node gastrinoma remains controversial.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author:
Authors: Martin J, Tedeschi M, Jackson J, Spalding D, Goldstone A,
Keywords: gastrinoma, lymph node,
#525 Pancreatic Neuroendocrine Tumors Associated with Mesenchimal Neoplasms of the GI Tract
Introduction: Neuroendocrine pancreatic tumors (NPT) are occasionally associated with mesenchimal tumors in neurofibromatosis type 1 but rarely in sporadic cases. We report five cases of NPT associated with other rare mesenchimal neoplasms of the GI tract, observed in our Department from 2003 to 2011.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Moletta L, Milanetto A, Alaggio R, Sperti C, Pedrazzoli S,
Keywords: pancreatic neuroendocrine tumors, GIST, pancreatic resection,
#277 Metastatic Gastrinoma Co-secreting PTHrP and ACTH
Introduction: Metastatic gastrinoma is occasionally associated with tumor secretion of functioning peptides, resulting in additional syndromes.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Joharatnam J, Carroll R, Galliford T, Downie B, Zissimopoulos A,
Keywords: metastatic gastrinoma, neuroendocrine tumour, co-secretion, PTHrP, ACTH,
Introduction: Gastrinomas represent a rare group of neuroendocrine tumors usually located in the duodenum or pancreas. They secrete gastrin, which is responsible for the clinical picture of severe acid-related peptic disease and diarrhea, known as the Zollinger-Ellison syndrome (ZES). While symptomatic control may be achieved with proton-pump inhibitors (PPIs) and somatostatin analogues (SSAs) treatment, little data is known regarding the possible anti-tumor effect of the peptide receptor radioligand therapy (PRRT) in gastrinoma patients.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author:
Authors: Grozinsky-Glasberg S, Barak D, Fraenkel M, Müeller J, Shimon I,
Keywords: PRRT, malignant gastrinoma, treatment, anti-tumor effect ,